58 related articles for article (PubMed ID: 23988111)
41. Origin of the Thiopyrone CTP-431 "Unexpectedly" Isolated from the Marine Sponge Cacospongia mycofijiensis.
Przeslak AD; Inman M; Lewis W; Moody CJ
J Org Chem; 2018 Sep; 83(17):10595-10601. PubMed ID: 30044092
[TBL] [Abstract][Full Text] [Related]
42. Asymmetric synthesis of a stereopentade fragment toward latrunculins.
Joyeux B; Gamet A; Casaretto N; Nay B
Beilstein J Org Chem; 2023; 19():428-433. PubMed ID: 37091733
[TBL] [Abstract][Full Text] [Related]
43. Deep-Sea Sponges and Corals off the Western Coast of Florida-Intracellular Mechanisms of Action of Bioactive Compounds and Technological Advances Supporting the Drug Discovery Pipeline.
Iskandar M; Ruiz-Houston KM; Bracco SD; Sharkasi SR; Calabi Villarroel CL; Desai MN; Gerges AG; Ortiz Lopez NA; Xiao Barbero M; German AA; Moluguri VS; Walker SM; Silva Higashi J; Palma JM; Medina DZ; Patel M; Patel P; Valentin M; Diaz AC; Karthaka JP; Santiago AD; Skiles RB; Romero Umana LA; Ungrey MD; Wojtkowiak A; Howard DV; Nurge R; Woods KG; Nanjundan M
Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132936
[TBL] [Abstract][Full Text] [Related]
44. BEX1 and BEX4 Induce GBM Progression through Regulation of Actin Polymerization and Activation of YAP/TAZ Signaling.
Lee S; Kang H; Shin E; Jeon J; Youn H; Youn B
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576008
[TBL] [Abstract][Full Text] [Related]
45. Cell Entry of C3 Exoenzyme from Clostridium botulinum.
Rohrbeck A; Just I
Curr Top Microbiol Immunol; 2017; 406():97-118. PubMed ID: 27832378
[TBL] [Abstract][Full Text] [Related]
46. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.
Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT
Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245
[TBL] [Abstract][Full Text] [Related]
47. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.
Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT
Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935
[TBL] [Abstract][Full Text] [Related]
48. A new dimension to the biosynthetic products isolated from the sponge Negombata magnifica.
Vilozny B; Amagata T; Mooberry SL; Crews P
J Nat Prod; 2004 Jun; 67(6):1055-7. PubMed ID: 15217296
[TBL] [Abstract][Full Text] [Related]
49. Bioactive natural and semisynthetic latrunculins.
El Sayed KA; Youssef DT; Marchetti D
J Nat Prod; 2006 Feb; 69(2):219-23. PubMed ID: 16499319
[TBL] [Abstract][Full Text] [Related]
50. Molecular Dynamics Simulation Reveal the Mechanism of Resistance of Mutant Actins to Latrunculin A - Insight into Specific Modifications to Design Novel Drugs to Overcome Resistance.
Lalitha R; R PK; Mohammed MM
Curr Comput Aided Drug Des; 2016; 12(2):107-18. PubMed ID: 27484118
[TBL] [Abstract][Full Text] [Related]
51. Differential binding of latrunculins to G-actin: a molecular dynamics study.
Helal MA; Khalifa S; Ahmed S
J Chem Inf Model; 2013 Sep; 53(9):2369-75. PubMed ID: 23988111
[TBL] [Abstract][Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
